Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for Handling Deviations and Incident Reports – V 2.0

Posted on By

API Manufacturing: SOP for Handling Deviations and Incident Reports – V 2.0

Standard Operating Procedure for Handling Deviations and Incident Reports in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/162/2025
Supersedes SOP/API/162/2022
Page No. Page 1 of 12
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To establish a standardized procedure for the identification, documentation, investigation, classification, and closure of deviations and incidents in API manufacturing processes, ensuring adherence to Good Manufacturing Practices (GMP), product quality, and regulatory compliance.

2. Scope

This SOP applies to all deviations and incidents occurring during the receipt, manufacturing, testing, packaging, and storage of raw materials, intermediates, APIs, and

related documentation within the facility.

3. Responsibilities

  • Initiator (Production/QC/Engineering/QA): Identify and report the deviation or incident.
  • Department Head: Provide initial evaluation and classify the deviation.
  • QA Officer: Review, investigate, and coordinate deviation closure.
  • QA Head: Final approver for deviation and incident closure, including CAPA justification.

4. Accountability

The Head of Quality Assurance is accountable for ensuring timely review, investigation, root cause analysis, and closure of all deviations and incidents reported under this SOP.

See also  API Manufacturing: SOP for Sample Receipt and Login in QC Lab - V 2.0

5. Procedure

5.1 Definitions

  • Deviation: Any departure from an approved instruction, procedure, specification, or expected practice.
  • Incident: An unplanned event that may or may not impact product quality or GMP compliance.

5.2 Types of Deviations

  • Planned Deviation: A pre-approved temporary change to a documented procedure or standard.
  • Unplanned Deviation: An unexpected non-conformance during operations, documentation, or environmental conditions.
  • Critical Deviation: A deviation likely to impact product quality or patient safety.
  • Major/Minor Deviation: Classified based on potential risk, as per QA guidelines.

5.3 Reporting the Deviation or Incident

  1. Any employee who observes a deviation must immediately inform their supervisor and fill the Deviation and Incident Notification Form (Annexure-1).
  2. Provide:
    • Description of the event
    • Date/time and location
    • Persons involved
    • Immediate corrective action (if any)
  3. Submit the completed form to QA within 24 hours of observation.

5.4 Initial QA Review and Classification

  1. QA reviews the notification and classifies the event:
    • Critical
    • Major
    • Minor
    • Planned/Unplanned
  2. QA assigns a unique Deviation Number (e.g., DEV/2025/024) and updates the Deviation Register (Annexure-2).

5.5 Investigation and Root Cause Analysis

  1. Initiate a formal investigation within 48 hours for critical/major deviations.
  2. Use tools such as:
    • 5 Whys
    • Ishikawa (Fishbone) Diagram
    • Brainstorming Sessions
  3. Document the findings and supporting evidence in the Investigation Report (Annexure-3).
See also  API Manufacturing: SOP for Out-of-Specification (OOS) Handling Procedure - V 2.0

5.6 CAPA (Corrective and Preventive Action)

  1. Propose CAPA based on investigation outcome:
    • Corrective Action – To address the immediate issue
    • Preventive Action – To prevent recurrence
  2. Assign responsibility and timelines for implementation.
  3. Track implementation in the CAPA Tracker (Annexure-4).

5.7 Review and Approval

  1. QA verifies the investigation and effectiveness of CAPA.
  2. Approve deviation closure only after all CAPA actions are completed and verified.
  3. Close the deviation formally and archive all records securely.

5.8 Planned Deviations

  1. Submit a Planned Deviation Request (Annexure-5) to QA before execution of the temporary change.
  2. Clearly mention:
    • Justification
    • Duration
    • Impact assessment
    • Temporary controls
  3. QA approves the planned deviation prior to implementation and monitors its closure post-expiry.

5.9 Trending and Periodic Review

  1. QA shall maintain deviation trends and submit quarterly summaries to management during review meetings.
  2. Analyze trends for:
    • Repetition by area or activity
    • Common root causes
    • Recurring personnel errors
  3. Initiate training or process improvements based on trends.

6. Abbreviations

  • QA: Quality Assurance
  • CAPA: Corrective and Preventive Action
  • GMP: Good Manufacturing Practices
  • OOS: Out of Specification

7. Documents

  1. Deviation and Incident Notification Form (Annexure-1)
  2. Deviation Register (Annexure-2)
  3. Investigation Report (Annexure-3)
  4. CAPA Tracker (Annexure-4)
  5. Planned Deviation Request Form (Annexure-5)
See also  API Manufacturing: SOP for Testing of Recovered Solvents for Reuse - V 2.0

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211.100 – Written Procedures; Deviations
  • WHO TRS No. 986 – Annex 2

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Deviation and Incident Notification Form

Date Initiator Description Immediate Action QA Initials
13/04/2025 Rajesh Kumar Wrong line sequence during batch setup Process stopped SN

Annexure-2: Deviation Register

Deviation No. Date Type Area Status
DEV/2025/024 13/04/2025 Unplanned Production Open

Annexure-3: Investigation Report

Deviation No. Root Cause Evidence Reviewed Conclusion
DEV/2025/024 Operator error Batch records and CCTV Retraining required

Annexure-4: CAPA Tracker

CAPA ID Description Owner Target Date Status
CAPA/2025/011 Retrain operators on batch setup QA 20/04/2025 In Progress

Annexure-5: Planned Deviation Request Form

Date Requested By Deviation Summary Justification QA Approval
12/04/2025 Sunita Reddy Use alternate filter for sampling Primary filter out of stock Approved

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP New Implementation QA Head
14/04/2025 2.0 Planned deviation form added Audit recommendation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Gel Manufacturing: SOP for Using Clean-In-Place (CIP) Systems for Gel Equipment – V 2.0
Next Post: Analytical Method Development: Comparison of FTIR Spectra in AMD – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version